Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Zhihong Chen (Shanghai, China), Zhihong Chen, Xiaoqiong Su, Jue Pan, Kan Xu, Xiangdong Wang. Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways. Eur Respir J 2016; 48: Suppl. 60, 1097

Member's Comments

No comment yet.

Related content which might interest you: Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Pim1 kinase affects allergic asthma in a HDM-driven mice model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Investigating the role of BAFF in murine models of allergic asthma Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 The effect of trehalose for the allergen-induced airway hyperresponsiveness and airway inflamation in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Rapamycin protects OVA induced asthma in mice through regulating autophagy Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models Source: International Congress 2015 – Advances in asthma and allergy in animal models Year: 2015 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model Source: International Congress 2015 – Asthma and lung immunology Year: 2015 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 LATE-BREAKING ABSTRACT: p-STAT6 and PU.1 are involved in IL-9 production by Th9 cells during allergen-induced late phase airway inflammation in asthma patients Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 ADEPT-derived, U-BIOPRED validated asthma clinical clusters with Th2 and non-Th2 phenotypes Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014